45 studies found for:    "Anthrax"
Show Display Options
Rank Status Study
21 Completed Trial of rPA-102 Vaccine in Healthy Adult Volunteers
Condition: Anthrax
Intervention: Biological: rPA102
22 Suspended A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109
Condition: Anthrax
Interventions: Biological: rPA vaccine containing alhydrogel 1.0 mL;   Drug: Normal Saline;   Biological: rPA vaccine containing alhydrogel 0.5 mL;   Biological: rPA vaccine containing alhydrogel 0.3 mL
23 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
24 Completed CDC Anthrax Vaccine Clinical Trial
Condition: Healthy
Intervention: Biological: BioThrax or Anthrax Vaccine Adsorbed
25 Recruiting Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed
Condition: Infections, Bacterial
Interventions: Biological: AVA;   Biological: Raxibacumab;   Drug: Diphenhydramine
26 Completed
Has Results
Ciprofloxacin BioThrax Co-Administration Study
Condition: Anthrax
Interventions: Biological: BioThrax;   Drug: Ciprofloxacin
27 Completed
Has Results
Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults
Condition: Anthrax
Intervention: Biological: BioThrax
28 Completed Placebo-Controlled, Sequential Group, Single Dose, Dose-Escalation Study to Evaluate the Safety and PK of ETI-204
Condition: Anthrax
Interventions: Drug: ETI-204, "Anthim";   Drug: placebo
29 Completed Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects
Condition: Anthrax
Interventions: Drug: Normal Saline for Injection;   Biological: MDX1303
30 Completed Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)
Condition: Anthrax
Interventions: Drug: AVP-21D9;   Drug: Placebo
31 Terminated Ph1 Study of Valortim and Doxycycline in Humans
Condition: Anthrax
Interventions: Drug: Doxycycline and Valortim;   Drug: Placebo Antibiotic and Valortim;   Drug: Placebo Antibiotic and Placebo Valortim
32 Suspended Ph1 Study of Valortim and Ciprofloxacin in Humans
Condition: Anthrax
Interventions: Drug: Ciprofloxacin and Valortim;   Drug: Placebo Antibiotic and Valortim;   Other: Placebo Antibiotic and Placebo Valortim
33 Completed VHA Clinicians and Bioterror Events: Interactive Web-based Learning
Conditions: Smallpox;   Anthrax
Intervention: Behavioral: BioCASES and BioTESTS
34 Completed Open-Label, Randomized, Parallel Group Study to Assess the Safety, Tolerability and PK of ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers
Condition: Inhalational Anthrax
Interventions: Biological: ETI-204;   Other: IV Ciprofloxacin;   Other: Oral Ciprofloxacin
35 Completed Safety, Tolerability, and PK of Single IM Doses of ETI-204 in Adult Volunteers
Condition: Inhalational Anthrax
Interventions: Biological: ETI-204;   Biological: Placebo
36 Completed Safety, Tolerability and PK of Repeat Administration of IV ETI-204
Condition: Inhalational Anthrax
Interventions: Biological: ETI-204;   Biological: Placebo
37 Completed A Study to Assess the Safety, Tolerability and PK of a Single IV Dose of ETI-204 in Adult Volunteers
Condition: Inhalational Anthrax
Interventions: Biological: ETI-204;   Biological: Placebo
38 Recruiting BioThrax® (Anthrax) Vaccine in Pregnancy Registry
Conditions: Pregnancy Complications;   Pregnancy Outcome;   Congenital Abnormalities
Intervention: Biological: Observational Intervention
39 Completed
Has Results
An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection
Condition: Therapeutic Treatment of Inhalation Anthrax
Intervention: Biological: Raxibacumab
40 Recruiting Special Drug Use Investigation of Ciproxan Injection in Pediatrics
Condition: Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax
Intervention: Drug: Cipro (Ciprofloxacin, BAYQ3939)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years